# Dianthus Therapeutics, Inc.: Form SC 13D/A, filed Apr 1, 2024

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: SC 13D/A
- Filed: 2024-04-01
- Accepted by EDGAR: Apr 1, 2024, 18:34 ET
- Period: not reported
- Accession: 0001193125-24-083707
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312524083707/d814099dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312524083707/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312524083707/d814099dsc13da.htm

Filed Apr 1, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-083707. Last ingested by Listed: Nov 10, 2026, 03:21 ET. No prices; not investment advice.